MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with A

Almotriptan

Almotriptan 12.5mg tablets

No stability information

Stability notes for Almotriptan 12.5mg tablets

There are no stability notes for this medicine.

Suppliers (7) of Almotriptan 12.5mg tablets
Almotriptan 12.5mg tablets (A A H Pharmaceuticals Ltd)
Almotriptan 12.5mg tablets (Accord-UK Ltd)
Almotriptan 12.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Almotriptan 12.5mg tablets (Healthcare Pharma Ltd)
Almotriptan 12.5mg tablets (Medihealth (Northern) Ltd)
Almotriptan 12.5mg tablets (Sigma Pharmaceuticals Plc)
Almotriptan 12.5mg tablets (Zentiva Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.